AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 284: F1245-F1254, 2003. First published February 11, 2003; doi:10.1152/ajprenal.00350.2002
0363-6127/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/6/F1245    most recent
00350.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sengul, S.
Right arrow Articles by Batuman, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sengul, S.
Right arrow Articles by Batuman, V.
Vol. 284, Issue 6, F1245-F1254, June 2003

Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells

Sule Sengul1,2, Craig Zwizinski1,2, and Vecihi Batuman1,2,3

1 Section of Nephrology, Department of Medicine, Tulane Medical Center, 3 Tulane Cancer Center, and 2 Veterans Administration Medical Center, New Orleans, Louisiana 70112

We previously demonstrated that light chain (LC) endocytosis by human proximal tubule cells (PTCs) leads to production of cytokines through activation of NF-kappa B. Here, we examined the role of MAPK pathways in these responses using four species of myeloma LCs (kappa 1, kappa 2, kappa 3, and lambda 1) previously shown to induce cytokine production by PTCs. Among these, kappa 1-LC, which yielded the strongest cytokine responses, was selected for detailed studies. Activation of MAPKs was probed by Western blot analysis for the active kinases, ERK 1/2, JNK 1/2, and p38 in kappa 1-LC-exposed human PTCs. To evaluate the functional role of MAPKs in LC-induced cytokine responses, we tested the effects of U-0126, an ERK inhibitor; SP-600125, an inhibitor of JNK; SB-203580, a p38 inhibitor; and curcumin, a JNK-AP-1 inhibitor, all added to media before 4-h exposure to 1.5 mg/ml kappa 1-LC. IL-6 and monocyte chemotactic protein-1 (MCP-1) were determined by ELISA. Both LC and human serum albumin (HSA) activated ERK, although the HSA effect was weaker. kappa 1-LC stimulated all three MAPKs, although phosphorylation of ERK was more pronounced and sustained than others. Inhibitors of ERK, JNK, and p38 reduced LC-induced IL-6 and MCP-1 production. These findings suggest that activation of MAPKs plays a role in LC-induced cytokine responses in PTCs. Activation of MAPKs may be involved in cytokine responses induced by other proteins as well as LCs and may be pivotal in the pathophysiology of tubulointerstitial injury in proteinuric diseases.

intracellular signaling mechanisms; interleukin-6; MCP-1; progression of renal diseases; myeloma; proteinuria


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Li, S. Balamuthusamy, E. E. Simon, and V. Batuman
Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cells
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F82 - F90.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Li, K. S. Hering-Smith, E. E. Simon, and V. Batuman
Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 860 - 870.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P.-X. Wang and P. W. Sanders
Immunoglobulin Light Chains Generate Hydrogen Peroxide
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1239 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Li, S. Cortez, T. Nakamachi, V. Batuman, and A. Arimura
Pituitary Adenylate Cyclase-Activating Polypeptide Is a Potent Inhibitor of the Growth of Light Chain-Secreting Human Multiple Myeloma Cells.
Cancer Res., September 1, 2006; 66(17): 8796 - 8803.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Arimura, M. Li, V. Batuman, W.F. Clark, A.K. Stewart, G.A. Rock, M. Sternbach, D.M. Sutton, B.J. Barrett, A.P. Heidenheim, et al.
Cast Nephropathy in Myeloma--Does PACAP38, a New Member of the Vasoactive Intestinal Peptide Family, Open a Therapeutic Window?: Potential Protective Action of Pituitary Adenylate Cyclase-Activiating Polypeptide (PACAP38) on In Vitro and In Vivo Models of Myeloma Kidney Injury. Blood 107: 661-668, 2006
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 911 - 919.
[Full Text] [PDF]

Home page
 BloodHome page
P. W. Sanders
A new twist in myeloma treatment
Blood, January 15, 2006; 107(2): 413 - 414.
[Full Text] [PDF]

Home page
 BloodHome page
A. Arimura, M. Li, and V. Batuman
Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury
Blood, January 15, 2006; 107(2): 661 - 668.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. B. S. Klassen, P. L. Allen, V. Batuman, K. Crenshaw, and T. G. Hammond
Light chains are a ligand for megalin
J Appl Physiol, January 1, 2005; 98(1): 257 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. Marra, W. Delogu, I. Petrai, S. Pastacaldi, A. Bonacchi, E. Efsen, S. Aleffi, C. Bertolani, M. Pinzani, and P. Gentilini
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G18 - G26.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.